Jodie Pope Morrison - Net Worth and Insider Trading

Jodie Pope Morrison Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jodie Pope Morrison owns 4 companies in total, including Aileron Therapeutics Inc (ALRN) , Akebia Therapeutics Inc (AKBA) , and Keryx Biopharmaceuticals Inc (KERX) among others .

Click here to see the complete history of Jodie Pope Morrison’s form 4 insider trades.

Insider Ownership Summary of Jodie Pope Morrison

Ticker	Comapny	Transaction Date	Type of Owner
ALRN	Aileron Therapeutics Inc	2017-06-28	director
AKBA	Akebia Therapeutics Inc	2018-12-12	director
KERX	Keryx Biopharmaceuticals Inc	2018-12-12	director & Interim CEO
ELDN	Eledon Pharmaceuticals Inc	2017-06-30	director

Jodie Pope Morrison Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jodie Pope Morrison Ownership Network

Ownership Network List of Jodie Pope Morrison

No Data

Ownership Network Relation of Jodie Pope Morrison

Jodie Pope Morrison Owned Company Details

What does Aileron Therapeutics Inc do?

Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects.

Who are the key executives at Aileron Therapeutics Inc?

Jodie Pope Morrison is the director of Aileron Therapeutics Inc. Other key executives at Aileron Therapeutics Inc include See Remarks Susan L. Drexler , VP & Finance and Operations Rick Wanstall , and SVP & Chief Business Officer Kathryn Gregory .

Aileron Therapeutics Inc (ALRN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aileron Therapeutics Inc (ALRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aileron Therapeutics Inc (ALRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aileron Therapeutics Inc (ALRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

NAS:ALRN Insider Transactions

20/Page

Total 0

Insider	Position	Date	Buy/Sell	Shares	Shares Owned	Trade Price($)	Trade Percentage(%)	Cost($1000)	Price change since trade(%)	Share ownership details	Filing Date

20/Page

Total 0

What does Akebia Therapeutics Inc do?

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes 1) Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease. 2) Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients. 3) HIF-PH inhibitors in preclinical development.

Who are the key executives at Akebia Therapeutics Inc?

Jodie Pope Morrison is the director of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Accounting Officer Violetta Cotreau , SVP & CFO and Treasurer David A Spellman , and SVP & Chief Medical Officer Steven Keith Burke .

Akebia Therapeutics Inc (AKBA) Insider Trades Summary

Over the past 18 months, Jodie Pope Morrison made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 22,809 shares made by Steven Keith Burke , a net sale of 130,500 shares made by John P. Butler , and a net sale of 30,502 shares made by Michel Dahan .

In summary, during the past 3 months, insiders sold 217,124 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 217,124 shares. During the past 18 months, 228,671 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 228,671 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

NAS:AKBA Insider Transactions

20/Page

Total 0

Insider	Position	Date	Buy/Sell	Shares	Shares Owned	Trade Price($)	Trade Percentage(%)	Cost($1000)	Price change since trade(%)	Share ownership details	Filing Date

20/Page

Total 0

What does Keryx Biopharmaceuticals Inc do?

Keryx Biopharmaceuticals Inc focuses on developing medicines to people with kidney diseases. The marketed product of the company is auryxia tablet, which is a iron based medicine.

Who are the key executives at Keryx Biopharmaceuticals Inc?

Jodie Pope Morrison is the director & Interim CEO of Keryx Biopharmaceuticals Inc. Other key executives at Keryx Biopharmaceuticals Inc include Chief Financial Officer Scott A Holmes , 10 percent owner Seth A Klarman , and director & 10 percent owner Baupost Group Llc/ma .

Keryx Biopharmaceuticals Inc (KERX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Keryx Biopharmaceuticals Inc (KERX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Keryx Biopharmaceuticals Inc (KERX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Keryx Biopharmaceuticals Inc (KERX)'s detailed insider trading history can be found in Insider Trading Tracker table.

NAS:KERX Insider Transactions

20/Page

Total 0

Insider	Position	Date	Buy/Sell	Shares	Shares Owned	Trade Price($)	Trade Percentage(%)	Cost($1000)	Price change since trade(%)	Share ownership details	Filing Date

20/Page

Total 0

What does Eledon Pharmaceuticals Inc do?

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.

Who are the key executives at Eledon Pharmaceuticals Inc?

Jodie Pope Morrison is the director of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include See Remarks Bryan E. Smith , CHIEF FINANCIAL OFFICER Paul Sean Little , and 10 percent owner Logos Global Management Lp .

Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary

Over the past 18 months, Jodie Pope Morrison made no insider transaction in Eledon Pharmaceuticals Inc (ELDN). Other recent insider transactions involving Eledon Pharmaceuticals Inc (ELDN) include a net purchase of 2,000 shares made by David-alexandre C Gros , and a net purchase of 1,000 shares made by Steven Perrin .

In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 3,000 shares were bought by its insiders, resulting in a net purchase of 3,000 shares.

Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

NAS:ELDN Insider Transactions

20/Page

Total 0

Insider	Position	Date	Buy/Sell	Shares	Shares Owned	Trade Price($)	Trade Percentage(%)	Cost($1000)	Price change since trade(%)	Share ownership details	Filing Date

20/Page

Total 0

Jodie Pope Morrison Mailing Address

Above is the net worth, insider trading, and ownership report for Jodie Pope Morrison. You might contact Jodie Pope Morrison via mailing address: C/o Tokai Pharmaceuticals, Inc., One Broadway, 14th Floor, Cambridge Ma 02142.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF ADV Part 2A ADV Part 2B ADV Part 3 Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.